Nvidia's Chip Demand Surge Amid AI Boom

Nvidia CEO Jensen Huang announced strong demand for its Blackwell chips, though there's an embargo on sales to China due to U.S. regulations. With partners like TSMC and Samsung, and competitors planning investments, the semiconductor sector anticipates a robust 'super cycle' driven by AI advancements.


Devdiscourse News Desk | Updated: 08-11-2025 09:38 IST | Created: 08-11-2025 09:38 IST
Nvidia's Chip Demand Surge Amid AI Boom
This image is AI-generated and does not depict any real-life event or location. It is a fictional representation created for illustrative purposes only.

Nvidia CEO Jensen Huang stated on Saturday that the semiconductor company's business is thriving due to significant demand for its advanced Blackwell chips. "Nvidia builds the GPU, but we also create the CPU, networking components, and switches, culminating in various chips integral to Blackwell," Huang explained at an event hosted by Nvidia's long-standing partner Taiwan Semiconductor Manufacturing Co (TSMC) in Hsinchu.

TSMC CEO C.C. Wei mentioned that Huang requested wafers, although the precise number remains confidential. Huang clarified there are "no active discussions" on selling Blackwell chips, Nvidia's leading AI product, to China, as the U.S. government has restricted such sales over concerns they might bolster China's military or AI industry.

In the midst of this, South Korea's SK Hynix disclosed it sold out future chip production and plans increased investments, anticipating an ongoing chip 'super cycle' propelled by AI growth. Samsung Electronics also reported engaging in "close discussion" to provide Nvidia with its upcoming high-bandwidth memory chips, HBM4.

TRENDING

DevShots

Latest News

OPINION / BLOG / INTERVIEW

Cyber-resilient electric mobility: AI shields EV charging stations from cyber-attacks

AI can decode medical records with near-human accuracy

New AI model could save historic monuments before they crumble

How AI systems must prove trust, transparency and reliability before clinical use

Connect us on

LinkedIn Quora Youtube RSS
Give Feedback